Literature DB >> 10048931

Crystal structures of the key anaerobic enzyme pyruvate:ferredoxin oxidoreductase, free and in complex with pyruvate.

E Chabrière1, M H Charon, A Volbeda, L Pieulle, E C Hatchikian, J C Fontecilla-Camps.   

Abstract

Oxidative decarboxylation of pyruvate to form acetyl-coenzyme A, a crucial step in many metabolic pathways, is carried out in most aerobic organisms by the multienzyme complex pyruvate dehydrogenase. In most anaerobes, the same reaction is usually catalyzed by a single enzyme, pyruvate:ferredoxin oxidoreductase (PFOR). Thus, PFOR is a potential target for drug design against certain anaerobic pathogens. Here, we report the crystal structures of the homodimeric Desulfovibrio africanus PFOR (data to 2.3 A resolution), and of its complex with pyruvate (3.0 A resolution). The structures show that each subunit consists of seven domains, one of which affords protection against oxygen. The thiamin pyrophosphate (TPP) cofactor and the three [4Fe-4S] clusters are suitably arranged to provide a plausible electron transfer pathway. In addition, the PFOR-pyruvate complex structure shows the noncovalent fixation of the substrate before the catalytic reaction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10048931     DOI: 10.1038/5870

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  52 in total

Review 1.  Biochemistry and evolution of anaerobic energy metabolism in eukaryotes.

Authors:  Miklós Müller; Marek Mentel; Jaap J van Hellemond; Katrin Henze; Christian Woehle; Sven B Gould; Re-Young Yu; Mark van der Giezen; Aloysius G M Tielens; William F Martin
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

Review 2.  Diversity and origins of anaerobic metabolism in mitochondria and related organelles.

Authors:  Courtney W Stairs; Michelle M Leger; Andrew J Roger
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-26       Impact factor: 6.237

3.  EPR spectroscopic and computational characterization of the hydroxyethylidene-thiamine pyrophosphate radical intermediate of pyruvate:ferredoxin oxidoreductase.

Authors:  Steven O Mansoorabadi; Javier Seravalli; Cristina Furdui; Vladimir Krymov; Gary J Gerfen; Tadhg P Begley; Jonathan Melnick; Stephen W Ragsdale; George H Reed
Journal:  Biochemistry       Date:  2006-06-13       Impact factor: 3.162

Review 4.  Acetogenesis and the Wood-Ljungdahl pathway of CO(2) fixation.

Authors:  Stephen W Ragsdale; Elizabeth Pierce
Journal:  Biochim Biophys Acta       Date:  2008-08-27

Review 5.  Evolutionary adaptations that enable enzymes to tolerate oxidative stress.

Authors:  James A Imlay; Ramakrishnan Sethu; Sanjay Kumar Rohaun
Journal:  Free Radic Biol Med       Date:  2019-02-06       Impact factor: 7.376

Review 6.  Metal centers in the anaerobic microbial metabolism of CO and CO2.

Authors:  Güneş Bender; Elizabeth Pierce; Jeffrey A Hill; Joseph E Darty; Stephen W Ragsdale
Journal:  Metallomics       Date:  2011-06-06       Impact factor: 4.526

7.  One-carbon chemistry of oxalate oxidoreductase captured by X-ray crystallography.

Authors:  Marcus I Gibson; Percival Yang-Ting Chen; Aileen C Johnson; Elizabeth Pierce; Mehmet Can; Stephen W Ragsdale; Catherine L Drennan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-28       Impact factor: 11.205

8.  Pyruvate:ferredoxin oxidoreductase is coupled to light-independent hydrogen production in Chlamydomonas reinhardtii.

Authors:  Jens Noth; Danuta Krawietz; Anja Hemschemeier; Thomas Happe
Journal:  J Biol Chem       Date:  2012-12-20       Impact factor: 5.157

9.  Chlamydomonas reinhardtii chloroplasts contain a homodimeric pyruvate:ferredoxin oxidoreductase that functions with FDX1.

Authors:  Robert van Lis; Carole Baffert; Yohann Couté; Wolfgang Nitschke; Ariane Atteia
Journal:  Plant Physiol       Date:  2012-11-15       Impact factor: 8.340

10.  An anaerobic-type alpha-ketoglutarate ferredoxin oxidoreductase completes the oxidative tricarboxylic acid cycle of Mycobacterium tuberculosis.

Authors:  Anthony D Baughn; Scott J Garforth; Catherine Vilchèze; William R Jacobs
Journal:  PLoS Pathog       Date:  2009-11-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.